Navigation Links
Startup to develop new solid-state technology at UCLA for use in medical imaging
Date:4/2/2010

While today many medical-imaging needs are being met with traditional vacuum tubebased technology, large segments of the X-rayimaging market are poorly served, and there is widespread demand for both performance improvements and cost reductions.

Based on groundbreaking patented technology licensed from UCLA, startup company Radius Health is developing a lightweight, flat-panel X-ray source Microemitter Array X-rays (MAX) technology that has the potential to address these needs by enabling new X-ray imaging applications while lowering the cost of traditional applications.

The startup has been selected to move into the UCLA on-campus incubator space at the California NanoSystems Institute to develop a lightweight X-ray emitter employing MAX technology an X-ray source on a chip capable of delivering the same spectrum as traditional sources.

The MAX technology was developed by Gil Travish, Ph.D., a research scientist in the UCLA Department of Physics and Astronomy, and his colleagues James Rosenzweig, a UCLA professor of physics, and Rodney Yoder, an assistant professor of physics at Manhattanville College in New York.

The MAX technology works like this: Using an array of particle sources from microfabricated structures, parallel X-rays are generated uniformly across a flat panel. The MAX source, which can be produced using the current generation of semiconductor foundry processes, generates diagnostic X-rays without the need for fragile vacuum tubes and bulky, expensive power electronics and radioactive materials.

The technology has the potential to deliver advanced and potentially safer imaging options than are available with current commercial X-ray systems, and to extend the 'application space' of X-ray radiology.

"Moving our development activities into CNSI is a real landmark moment for us," said Mark Evans, CEO for Radius Health. "The access to the facilities and knowledge will greatly help us accelerate our product to market and bring this key technology nearer to deployment in clinical systems."

Radius Health expects to make extensive use of the microfabrication facilities at the new Integrated Systems Nanofabrication Cleanroom at CNSI.

The use of pyroelectric emission is important, as the voltage required to generate electrons within the X-ray production process is produced within a crystal, eliminating the need for 'clean' power supplies, transformers, high-voltage electronics and the associated shielding required and most importantly, fragile vacuum tubes.

Unlike past efforts with pyroelectric-based sources, Radius Health is able to control the emission of electrons and thus maintain a stable and controlled emission of X-rays, which allows this type of source to be applied to clinical applications.

The journey from vacuum tubes to flat panels could be as transformational in X-rays as it has been in visual displays.

"In most areas of electronic product development, such as computing, displays and radar, solid-state technology has replaced vacuum-tube technology due to the improvements in reliability, energy consumption and portability," Travish said. "We see this story being extended to X-ray sources."


'/>"/>

Contact: Jennifer Marcus
jmarcus@cnsi.ucla.edu
310-267-4839
University of California - Los Angeles
Source:Eurekalert

Related medicine news :

1. Silicon Valley Entrepreneur Launches Startup to Accelerate Tech Entrepreneurship in Upstate New York
2. Informatics experts contribute to special Health Affairs edition on e-health in the developing world
3. Michael J. Fox Foundation Awards $2.8 Million to Drive Development of Parkinsons Disease Biomarker Pipeline
4. Developing a cyberinfrastructure for comparative effectiveness in cancer research
5. Oakland University William Beaumont School of Medicine Reaches Development Milestone
6. Electrical Muscle Stimulation Proven to Enhance Muscle Development and Sports Performance
7. Entest BioMedical Enters into LOI with Advanced Light Devices to Develop Laser Platform for Stem Cell / Laser COPD Treatment
8. New York City Surgeon Develops All-Natural Treatment for Wrinkles and Scars
9. FDA Collaboration Seeks to Speed Development of Pneumococcal Vaccines for Children in Developing Countries
10. University of Alberta researchers develop drug interface to save lives
11. The Colorado Institute for Drug, Device and Diagnostic Development Launches With a Statewide Call for Proposals From Life Science Technologies in Need of Funding and Active Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 2016 , ... Finally, a bruise cream that really works. Originally designed ... into the post-surgical treatment plans of a variety of other procedures including, but not ... effective for bruising and causes a rapid resolution of bruising and inflammatory changes compared ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, InhaleLabs.com (Inhale) offilially ... their medication by matching users with high quality water pipes within an ideal price ... commitment. , Inhale was founded by two brothers, Nick and Mike Hunter, who use ...
(Date:6/23/2016)... ... June 23, 2016 , ... Terumo BCT, ... organization responsible for clinical transfusion research programs and for the blood supply in ... Evaluation and Predictive Analytical Rating Score (PREPAReS) study. , Currently in its ...
(Date:6/23/2016)... ... June 23, 2016 , ... The Mechille Wilson Agency, ... throughout Jasper County and the surrounding region, is initiating a charity drive to assist ... raise funds earmarked for a scholarship fund that will be presented to the chosen ...
(Date:6/23/2016)... , ... June 23, 2016 , ... Representatives of CHA ... the newest member of their staff, Dr. Joshua J. Berger. As of May ... of the world-renowned facility. , Dr. Berger has received recognition for his research, his ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... 24, 2016 ... the addition of the " Global Markets for ... This report focuses on ... updated review, including its applications in various applications. The ... which includes three main industries: pharmaceutical and biotechnology, food ...
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
Breaking Medicine Technology: